Incyte (INCY)
Add to Watchlists Create an AlertIncyte News
Why Immunotherapy Stocks Could Be Set for a Big Move
Fool May 24The American Society of Clinical Oncology's annual meeting kicks off late next week, and this group of stocks looks primed to impress analysts and investors alike.
Incyte to Present at Upcoming Investor Conferences
Business Wire May 22Incyte Corporation announced today it will present at the following investor conferences during the month of June:
Incyte Corporation CEO Presents at UBS Global Healthcare Conference (Transcript)
Seeking Alpha May 20Incyte Corporation CEO Presents at UBS Global Healthcare Conference (Transcript)
Incyte's Management Presents at Bank of America Merrill Lynch 2013 Health Care Conference (Transcript)
Seeking Alpha May 15Incyte's Management Presents at Bank of America Merrill Lynch 2013 Health Care Conference (Transcript)
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Incyte Corporation of Class Action Lawsuit and Upcoming Deadline -- INCY
GlobeNewswire May 10NEW YORK -- Pomerantz Grossman Hufford Dahlstrom & Gross LLP has filed a class action lawsuit against Incyte Corporation ("Incyte" or the "Company") and certain of its officers. The ...
INCYTE CORP Financials
May 10Goldman Sachs Resumes Incyte (INCY) at Sell, Competition to Roil Jakafi Launch
Street Insider May 7Alnylam Narrows Loss, Sales Fall - Analyst Blog
Zacks May 7Alnylam's first quarter 2013 loss of 15 cents per share was narrower than the Zacks Consensus Estimate of a loss of 31 cents.
Arena Pharma Narrows Loss - Analyst Blog
Zacks May 6Arena's loss of 10 cents per share in the first quarter of 2013 was narrower than the year-ago loss of 15 cents per share
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| INCY | 22.99 | +0.82 | +3.70% | 3.121B |
